Steven Cohen Ptc Therapeutics, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $29.8 Million - $38.5 Million	-700,000 Reduced 73.68%	250,000 $12.7 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $17.8 Million - $32.6 Million	550,000 Added 137.5%	950,000 $42.4 Million
Q3 2019 Nov 15, 2019	BUY	$33.82 - $48.17 $13.5 Million - $19.3 Million	400,000 New	400,000 $13.5 Million

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.